Literature DB >> 20308800

Identification and characterization of rat RhoA gene promoter.

Yoshihiko Chiba1, Kumiko Goto, Kimihiko Matsusue, Shioko Kimura, Miwa Misawa.   

Abstract

RhoA upregulation has been suggested in bronchial smooth muscles (BSMs) of asthmatic rats. Here, we cloned/characterized the 5'-promoter region of the rat rhoA. A transcription-initiation site was identified at 66-bp upstream of the reference sequence, GenBank-BC061732. Luciferase assay using interleukin-13 (IL-13)-stimulated cells revealed a significant promoter activity at 238- to 166-bp upstream of the transcription-initiation site, which contains a signal transducer and activation of transcription (STAT) 6-binding region. The IL-13-induced increase in luciferase activity was inhibited by a STAT6 inhibitor, AS1517499, or a Janus kinases (JAKs) inhibitor, JAK Inhibitor-I, but not by tyrphostin-AG490, WHI-P131, or tyrphostin-AG9 (selective JAK2, JAK3, and Tyk2 inhibitors, respectively). Thus, rat BSM rhoA expression may have causal relation to the IL-13-JAK1-STAT6 signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308800      PMCID: PMC3486724          DOI: 10.1254/jphs.09346sc

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  17 in total

1.  Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations.

Authors:  J Prieto; C Lensmar; A Roquet; I van der Ploeg; D Gigliotti; A Eklund; J Grunewald
Journal:  Respir Med       Date:  2000-08       Impact factor: 3.415

2.  Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization.

Authors:  A Yoshii; K Iizuka; K Dobashi; T Horie; T Harada; T Nakazawa; M Mori
Journal:  Am J Respir Cell Mol Biol       Date:  1999-06       Impact factor: 6.914

3.  Augmented acetylcholine-induced, Rho-mediated Ca2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats.

Authors:  Y Chiba; Y Takada; S Miyamoto; M MitsuiSaito; H Karaki; M Misawa
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

4.  Synthesis and evaluation of 2-{[2-(4-hydroxyphenyl)-ethyl]amino}pyrimidine-5-carboxamide derivatives as novel STAT6 inhibitors.

Authors:  Shinya Nagashima; Masaki Yokota; Ei-Ichi Nakai; Sadao Kuromitsu; Keiko Ohga; Makoto Takeuchi; Shin-Ichi Tsukamoto; Mitsuaki Ohta
Journal:  Bioorg Med Chem       Date:  2006-10-27       Impact factor: 3.641

Review 5.  RhoA/Rho-kinase as a therapeutic target in asthma.

Authors:  Hiroaki Kume
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

6.  TMC-264, a novel inhibitor of STAT6 activation produced by Phoma sp. TC 1674.

Authors:  Masaaki Sakurai; Maki Nishio; Kouzou Yamamoto; Toru Okuda; Kimio Kawano; Tetsuo Ohnuki
Journal:  J Antibiot (Tokyo)       Date:  2003-06       Impact factor: 2.649

7.  Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein.

Authors:  Yoshihiko Chiba; Shuji Nakazawa; Michiko Todoroki; Koji Shinozaki; Hiroyasu Sakai; Miwa Misawa
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-07       Impact factor: 6.914

8.  Upregulation of rhoA mRNA in bronchial smooth muscle of antigen-induced airway hyperresponsive rats.

Authors:  Yoshihiko Chiba; Hiroyasu Sakai; Hiroshi Wachi; Hideki Sugitani; Yoshiyuki Seyama; Miwa Misawa
Journal:  J Smooth Muscle Res       Date:  2003-12

Review 9.  Interleukin-13 in asthma pathogenesis.

Authors:  Marsha Wills-Karp
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

10.  Involvement of RhoA-mediated Ca2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice.

Authors:  Yoshihiko Chiba; Ayako Ueno; Koji Shinozaki; Hisao Takeyama; Shuji Nakazawa; Hiroyasu Sakai; Miwa Misawa
Journal:  Respir Res       Date:  2005-01-08
View more
  2 in total

Review 1.  Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases.

Authors:  Eirini Nomikou; Melina Livitsanou; Christos Stournaras; Dimitris Kardassis
Journal:  Cell Mol Life Sci       Date:  2018-03-02       Impact factor: 9.261

2.  Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses.

Authors:  Shigeru Ashino; Katsuyuki Takeda; Hui Li; Vanessa Taylor; Anthony Joetham; Polly R Pine; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2013-12-22       Impact factor: 10.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.